Article

A guide to identifying suitable patient-derived cancer models in CancerModels.Org

2023-12-15

Abstract excerpt

Patient-derived cancer models (PDCMs) have become an essential tool in both cancer research and preclinical studies. Each model type offers unique advantages and is better suited for specific research areas: cell lines are low cost and allow high throughput assays, organoids model the impact of intratumour heterogeneity, tumour evolution, and drug response, and patient-derived xenografts (PDXs) retain the tumour a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb2f4bfd-8d41-527d-8d3f-783d9c58f7b4
DOI: 10.6019/tol.cancermodelsorg-w.2023.00001.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A guide to identifying suitable patient-derived cancer models in CancerModels.OrgDOI 10.6019/tol.cancermodelsorg-w.2023.00001.1Read

Modeling colorectal cancer: A bio‐resource of 50 patient‐derived organoid linesSemantic proximity Read

Navigating Multi-scale Cancer Systems Biology towards Model-driven Personalized TherapeuticsSemantic proximity Read

PDXNet Portal: Patient-Derived Xenograft model, data, workflow, and tool discoverySemantic proximity Read

XENTURION, a multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients for population-level translational oncologySemantic proximity Read

PDX Finder: A Portal for Patient-Derived tumor Xenograft Model DiscoverySemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Cell Model Passports—a hub for clinical, genetic and functional datasets of preclinical cancer modelsSemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Optimized large-scale longitudinal biorepository of gastroesophageal adenocarcinoma patient-derived organoids: High-fidelity models for personalized treatment to overcome resistanceSemantic proximity Read

Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid modelsSemantic proximity Read

A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacologySemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read